Study of an Innovative Therapy Using CAR-T Cells Targeting IL-1RAP in Patients With High-Risk Myelodysplastic Syndromes (MDS
Clinical trial NCT07455500 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07455500
- Sponsor
- University Hospital, Grenoble
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-01
- Primary completion
- 2030-01-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.